Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 25; no. 2; pp. 375 - 379
Main Authors:	Otten, J, Schmitz, L, Vettorazzi, E, Schultze, A, Marx, A H, Simon, R, Krauter, J, Loges, S, Sauter, G, Bokemeyer, C, Fiedler, W
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-02-2011 Nature Publishing Group
Subjects:	692/53/2422 692/699/67/1990/283/1897 Activin Receptors, Type II - analysis Acute myeloid leukemia Adult Biological and medical sciences Cancer Research Critical Care Medicine Female Gene expression Genetic aspects Hematologic and hematopoietic diseases Hematology Humans Indexing in process Intensive Internal Medicine letter-to-the-editor Leukemia Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Medicine Medicine & Public Health Middle Aged Oncology Physiological aspects Prognosis Protein kinases Protein-Serine-Threonine Kinases - analysis Receptors, Transforming Growth Factor beta - analysis Transforming growth factors Treatment Outcome Young Adult Germany Human Acute myelogenous leukemia Prognosis Hematology Transforming growth factor β C-Onc gene Malignant hemopathy Anaplastic lymphoma kinase Protooncogene Cancer Biological receptor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2010.273